A clinicopathological and immunohistochemical study of clinically non-functioning pituitary adenomas: A single institutional experience

Neurology India

Volumn 58, Issue 3, 2010, Pages 418-423

  Rishi, Arvind ^a   Sharma, Mehar C ^a   Sarkar, Chitra ^a   Jain, Deepali ^a   Singh, Manmohan ^a   Mahapatra, Ashok Kumar ^a   Mehta, Veer Singh ^a   Das, Tapos Kumar ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Immunohistochemistry; neoplasia; non functional adenomas; pituitary adenoma; pituitary gland; sellar tumors

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; FOLLITROPIN BETA SUBUNIT; KI 67 ANTIGEN; LUTEINIZING HORMONE BETA SUBUNIT; CORTICOTROPIN; FOLLITROPIN;

ADULT; AGED; ALPHA CHAIN; ARTICLE; CARCINOGENESIS; CORRELATION ANALYSIS; FEMALE; GONADOTROPH ADENOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; INDIA; INVASIVE CARCINOMA; INVASIVE PROCEDURE; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; NON FUNCTIONING PITUITARY ADENOMA; NULL CELL ADENOMA; OBSERVATION; PROTEIN EXPRESSION; ADENOMA; ADOLESCENT; AGE; CLASSIFICATION; HYPOPHYSIS TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; SEX DIFFERENCE; YOUNG ADULT;

ADENOMA; ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; ADULT; AGE FACTORS; AGED; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; KI-67 ANTIGEN; LUTEINIZING HORMONE, BETA SUBUNIT; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SEX FACTORS; YOUNG ADULT;

EID: 77955065593     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.66336     Document Type: Article

References (52)

1. Kovacs K, Scheithauer BW, Horvath E, Lloyd RV. The World Health Organization classification of adenohypophysial neoplasms. A proposed five-tier scheme. Cancer 1996;78:502-510
2. McNicol AM. Pituitary adenomas. Histopathology 1987;11:995-1011.
3. Liuzzi A, Tassi V, Pirro MT, Zingrillo M, Ghiggi MR, Chiodini I, et al. Nonfunctioning adenomas of the pituitary. Metabolism 1996;45:80-82
4. Snyder PJ. Clinically nonfunctioning pituitary adenomas. Endocrinol Metab Clin North Am 1993;22:163-175
5. DeStephano DB, Lloyd RV, Pike AM, Wilson BS. Pituitary adenomas. An immunohistochemical study of hormone production and chromogranin localization. Am J Pathol 1984;116:464-472
6. Daniely M, Aviram A, Adams EF, Buchfelder M, Barkai G, Fahlbusch R, et al. Comparative genomic hybridization analysis of nonfunctioning pituitary tumors. J Clin Endocrinol Metab 1998;83:1801-1805
7. Alexander JM, Biller BM, Bikkal H, Zervas NT, Arnold A, Klibanski A. Clinically nonfunctioning pituitary tumors are monoclonal in origin. J Clin Invest 1990;86:336-340
8. Schulte HM, Oldfield EH, Allolio B, Katz DA, Berkman RA, Ali IU. Clonal composition of pituitary adenomas in patients with Cushing's disease: determination by X-chromosome inactivation analysis. J Clin Endocrinol Metab 1991;73:1302-1308
9. Asa SL, Kovacs K, Horvath E, Losinski NE, Laszlo FA, Domokos I, et al. Human fetal adenohypophysis. Electron microscopic and ultrastructural immunocytochemical analysis. Neuroendocrinology 1988;48:423-431
10. Asa SL, Gerrie BM, Singer W, Horvath E, Kovacs K, Smyth HS. Gonadotropin secretion in vitro by human pituitary null cell adenomas and oncocytomas. J Clin Endocrinol Metab 1986;62:1011-1019
11. Fisher BJ, Gaspar LE, Noone B. Giant pituitary adenomas: role of radiotherapy. Int J Radiat Oncol Biol Phys 1993;25:677-681
12. Grigsby PW, Thomas PR, Simpson JR, Fineberg BB. Long-term results of radiotherapy in the treatment of pituitary adenomas in children and adolescents. Am J Clin Oncol 1988;11:607-611
13. Harris PE. Biochemical markers for clinically non-functioning pituitary tumours. Clin Endocrinol (Oxf) 1998;49:163-164
14. Mindermann T, Wilson CB. Pediatric pituitary adenomas. Neurosurgery 1995;36:259-68; discussion 69.
15. Mizutani T, Teramoto A, Aruga T, Takakura K, Sanno N. Prepubescent pituitary null cell macroadenoma with silent macroscopic apoplexy: case report. Neurosurgery 1993;33:907-9; discussion 09-10.
16. Partington MD, Davis DH, Laws ER Jr, Scheithauer BW. Pituitary adenomas in childhood and adolescence. Results of transsphenoidal surgery. J Neurosurg 1994;80:209-216
17. Dyer EH, Civit T, Visot A, Delalande O, Derome P. Transsphenoidal surgery for pituitary adenomas in children. Neurosurgery 1994;34:207-212
18. Mindermann T, Wilson CB. Age-related and gender-related occurrence of pituitary adenomas. Clin Endocrinol (Oxf) 1994;41:359-364
19. Orukaptan HH, Senmevsim O, Ozcan OE, Ozgen T. Pituitary adenomas: results of 684 surgically treated patients and review of the literature. Surg Neurol 2000;53:211-219
20. Turner HE, Adams CB, Wass JA. Pituitary tumours in the elderly: a 20 year experience. Eur J Endocrinol 1999;140:383-389
21. Sarkar C, Roy S, Kochupillai N, Gupta N, Tandon PN. A clinico-pathologic study of pituitary adenomas. Indian J Med Res 1990;92:315-323
22. Kovacs K, Horvath E, Ryan N, Ezrin C. Null cell adenoma of the human pituitary. Virchows Arch A Pathol Anat Histol 1980;387:165-174
23. Nomikos P, Ladar C, Fahlbusch R, Buchfelder M. Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas - a study on 721 patients. Acta Neurochir (Wien) 2004;146:27-35.
24. Schaller B. Gender-related differences in non-functioning pituitary adenomas. Neuro Endocrinol Lett 2003;24:425-430
25. Klibanski A, Zervas NT, Kovacs K, Ridgway EC. Clinically silent hypersecretion of growth hormone in patients with pituitary tumors. J Neurosurg 1987;66:806-811
26. Pickett CA. Diagnosis and management of pituitary tumors: recent advances. Prim Care 2003;30:765-789
27. Mukai K. Pituitary adenomas. Immunocytochemical study of 150 tumors with clinicopathologic correlation. Cancer 1983;52:648-653
28. Greenman Y, Tordjman K, Sömjen D, Reider-Groswasser I, Kohen F, Ouaknine G, et al. The use of beta-subunits of gonadotrophin hormones in the follow-up of clinically non-functioning pituitary tumours. Clin Endocrinol (Oxf) 1998;49:185-190
29. Chanson P, Pantel J, Young J, Couzinet B, Bidart JM, Schaison G. Free luteinizing-hormone beta-subunit in normal subjects and patients with pituitary adenomas. J Clin Endocrinol Metab 1997;82:1397-1402
30. Ho DM, Hsu CY, Ting LT, Chiang H. The clinicopathological characteristics of gonadotroph cell adenoma: a study of 118 cases. HumPathol 1997;28:905-911
31. Miura M, Matsukado Y, Kodama T, Mihara Y. Clinical and histopathological characteristics of gonadotropin-producing pituitary adenomas. J Neurosurg 1985;62:376-382
32. Kourides IA, Ridgway EC, Weintraub BD, Bigos ST, Gershengorn MC, Maloof F. Thyrotropin-induced hyperthyroidism: use of alpha and beta subunit levels to identify patients with pituitary tumors. J Clin Endocrinol Metab 1977;45:534-543
33. Kovacs K, Horvath E, Ezrin C, Weiss MH. Adenoma of the human pituitary producing growth hormone and thyrotropin. A histologic, immunocytologic and fine-structural study. Virchows Arch A Pathol Anat Histol 1982;395:59-68.
34. Jaquet P, Hassoun J, Delori P, Gunz G, Grisoli F, Weintraub BD. A human pituitary adenoma secreting thyrotropin and prolactin: immunohistochemical, biochemical, and cell culture studies. J Clin Endocrinol Metab 1984;59:817-824
35. Peterson RE, Kourides IA, Horwith M, Vaughan ED Jr, Saxena BB, Fraser RA. Luteinizing hormone- and alpha-subunit-secreting pituitary tumor: positive feedback of estrogen. J Clin Endocrinol Metab 1981;52:692-698
36. Dekkers OM, Pereira AM, Romijn JA. Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas. J Clin Endocrinol Metab 2008;93:3717-3726
37. Molitch ME. Nonfunctioning pituitary tumors and pituitary incidentalomas. Endocrinol Metab Clin North Am 2008;37:151-171
38. Scheithauer BW, Jaap AJ, Horvath E, Kovacs K, Lloyd RV, Meyer FB, et al. Clinically silent corticotroph tumors of the pituitary gland. Neurosurgery 2000;47:723-9; discussion 729-730
39. Lath R, Chacko G, Chandy MJ. Determination of Ki-67 labeling index in pituitary adenomas using MIB-1 monoclonal antibody. Neurol India. 2001;49:144-147
40. Tateno T, Izumiyama H, Doi M, Yoshimoto T, Shichiri M, Inoshita N, et al. Differential gene expression in ACTH -secreting and non-functioning pituitary tumors. Eur J Endocrinol 2007;157:717-724
41. Bradley KJ, Wass JA, Turner HE. Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently. Clin Endocrinol (Oxf) 2003;58:59-64.
42. Mastronardi L, Guiducci A, Spera C, Puzzilli F, Liberati F, Maira G. Ki-67 labelling index and invasiveness among anterior pituitary adenomas: analysis of 103 cases using the MIB-1 monoclonal antibody. J Clin Pathol 1999;52:107-111
43. Ekramullah SM, Saitoh Y, Arita N, Ohnishi T, Hayakawa T. The correlation of Ki-67 staining indices with tumour doubling times in regrowing non-functioning pituitary adenomas. Acta Neurochir (Wien) 1996;138:1449-1455
44. Abe T, Sanno N, Osamura YR, Matsumoto K. Proliferative potential in pituitary adenomas: measurement by monoclonal antibody MIB-1. Acta Neurochir (Wien) 1997;139:613-618
45. Birman P, Michard M, Li JY, Peillon F, Bression D. Epidermal growth factor-binding sites, present in normal human and rat pituitaries, are absent in human pituitary adenomas. J Clin Endocrinol Metab 1987;65:275-281
46. Yonezawa K, Tamaki N, Kokunai T. Clinical features and growth fractions of pituitary adenomas. Surg Neurol 1997;48:494-500.
47. Hentschel SJ, McCutcheon E, Moore W, Durity FA. P53 and MIB- 1 immunohistochemistry as predictors of the clinical behavior of nonfunctioning pituitary adenomas. Can J Neurol Sci 2003;30:215-219
48. Wolfsberger S, Wunderer J, Zachenhofer I, Czech T, Böcher-Schwarz HG, Hainfellner J, et al. Expression of cell proliferation markers in pituitary adenomas-correlation and clinical relevance of MIB-1 and anti-topoisomerase- IIalpha. Acta Neurochir (Wien) 2004;146:831-839
49. Fan X, Childs GV. Epidermal growth factor and transforming growth factor-alpha messenger ribonucleic acids and their receptors in the rat anterior pituitary: localization and regulation. Endocrinology 1995;136:2284-2293
50. Dahia PL, Grossman AB. The molecular pathogenesis of corticotroph tumors. Endocr Rev 1999;20:136-155
51. Chaidarun SS, Eggo MC, Sheppard MC, Stewart PM. Expression of epidermal growth factor (EGF), its receptor, and related oncoprotein (erbB-2) in human pituitary tumors and response to EGF in vitro. Endocrinology 1994;135:2012-2021
52. Theodoropoulou M, Arzberger T, Gruebler Y, Jaffrain-Rea ML, Schlegel J, Schaaf L, et al. Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells. J Endocrinol 2004;183:385-394